dc.contributor.author |
Wright, SP |
en |
dc.contributor.author |
Doughty, Robert |
en |
dc.contributor.author |
Frampton, CM |
en |
dc.contributor.author |
Gamble, Gregory |
en |
dc.contributor.author |
Yandle, TG |
en |
dc.contributor.author |
Richards, AM |
en |
dc.coverage.spatial |
United States |
en |
dc.date.accessioned |
2012-03-26T02:30:21Z |
en |
dc.date.issued |
2009 |
en |
dc.identifier.citation |
Circulation: Heart Failure 2(5):465-471 2009 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/15354 |
en |
dc.description.abstract |
The urocortins are emerging as potentially important contributors to neurohumoral regulation of the circulation with recent reports attributing a powerful array of hemodynamic, renal, and neurohumoral effects to the urocortins in cardiac failure. These peptides also seem to have cardioprotective effects in the setting of ischemia-reperfusion. Little is known concerning the plasma concentrations of the urocortins in health and disease. We have investigated plasma urocortin 1 as a potential diagnostic marker of heart failure and documented its relationships to symptoms, measures of cardiac function, and concurrent levels of other circulating neurohormones. |
en |
dc.language |
eng |
en |
dc.publisher |
American Heart Association, Inc |
en |
dc.relation.ispartofseries |
Circulation: Heart Failure |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Adrenomedullin |
en |
dc.subject |
Adult |
en |
dc.subject |
Aged |
en |
dc.subject |
Aged, 80 and over |
en |
dc.subject |
Biological Markers |
en |
dc.subject |
Creatinine |
en |
dc.subject |
Endothelin-1 |
en |
dc.subject |
Female |
en |
dc.subject |
Heart Failure |
en |
dc.subject |
Humans |
en |
dc.subject |
Logistic Models |
en |
dc.subject |
Male |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
Natriuretic Peptides |
en |
dc.subject |
Predictive Value of Tests |
en |
dc.subject |
Prospective Studies |
en |
dc.subject |
ROC Curve |
en |
dc.subject |
Severity of Illness Index |
en |
dc.subject |
Up-Regulation |
en |
dc.subject |
Urocortins |
en |
dc.subject |
Ventricular Function, Left |
en |
dc.title |
Plasma urocortin 1 in human heart failure. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1161/CIRCHEARTFAILURE.108.840207 |
en |
pubs.issue |
5 |
en |
pubs.begin-page |
465 |
en |
pubs.volume |
2 |
en |
dc.rights.holder |
Copyright: American Heart Association, Inc. |
en |
dc.identifier.pmid |
19808377 |
en |
pubs.end-page |
471 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
117870 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
1941-3297 |
en |
dc.identifier.pii |
CIRCHEARTFAILURE.108.840207 |
en |
pubs.record-created-at-source-date |
2012-07-30 |
en |
pubs.dimensions-id |
19808377 |
en |